LIPOCINE INC. Deferred State and Local Income Tax Expense (Benefit)
LIPOCINE INC. (LPCN) reported Deferred State and Local Income Tax Expense (Benefit) of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2016-03-10.
Discontinued › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2016-03-10
- LIPOCINE INC. deferred state and local income tax expense (benefit) for fiscal 2014 was $0.00.
- LIPOCINE INC. deferred state and local income tax expense (benefit) for fiscal 2013 was $0.00.
- LIPOCINE INC. deferred state and local income tax expense (benefit) for fiscal 2012 was $0.00.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month |
|---|---|
| 2014-12-31 | $0.00 10-K · filed 2016-03-10 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-11 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |